Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation.
Nonalcoholic steatohepatitis (NASH) may progress to cirrhosis and lead to liver failure. Histologically, NASH is often indistinguishable from liver disease caused by alcohol use; the cause of NASH remains unknown. A subgroup of patients with NASH eventually develops fibrosis and/or cirrhosis, and in many cases, transplantation is performed for end-stage liver disease attributed to steatohepatitis in patients who do not consume alcohol. The patient described received a transplant for end-stage liver disease secondary to NASH with cirrhosis. Postoperatively she did well, with a bout of mild rejection treated successfully at week 9 with prompt normalization of liver tests. Weight and glycemic control were optimized, and steroid therapy was minimized as safely as possible. Repeat liver biopsy at week 66, however, for persistent mild elevation of alkaline phosphatase and gamma-glutamyl-transferase surprisingly revealed the "recurrence" of NASH. Subsequent biopsy revealed NASH with cirrhosis by week 76 after transplantation. Subsequent biopsy at week 87 has confirmed cirrhosis. The patient does not consume alcohol. It is believed to be the first reporting of such a case.
Molloy
R M
RM
Department of Medicine, Medical College of Wisconsin, Milwaukee, USA.
Komorowski
R
R
Varma
R R
RR
D001706:Biopsy; D005234:Fatty Liver / Q000473:pathology*; D005260:Female; D006505:Hepatitis / Q000473:pathology*; D006801:Humans; D016031:Liver Transplantation / Q000473:pathology*; D008875:Middle Aged; D012008:Recurrence